Aegle marmelos fruit extract abates dextran sodium sulfate induced acute colitis in mice: Repression of pro-inflammatory cytokines during colonic inflammation

Biomedicine and Preventive Nutrition

Volumn 4, Issue 2, 2014, Pages 307-317

  Kasinathan, Nirmal Kumar ^a   Subramaniya, Bharathi Raja ^a   Pandian, Ilakkiya ^a   Sivasithamparam, Niranjali Devaraj ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Aegle marmelos fruit extract; Anti inflammation; DSS colitis; HPLC; IBD; Lupeol; Molecular docking; NF B; Phytomedicine

Indexed keywords

AEGLE MARMELOS EXTRACT; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; LUPEOL; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UMBELLIFERONE;

ACUTE DISEASE; AEGLE MARMELOS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; GENE REPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; MALE; MOLECULAR DOCKING; MOUSE; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION;

AEGLE MARMELOS; MUS;

EID: 84901622127     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2014.03.002     Document Type: Article

References (49)

1. Podolsky D.K. The future of IBD treatment. J Gastroenterol 2003, 38(Suppl. 15):63-66.
2. Delco F., Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut 2000, 46:500-506.
3. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta analysis. Gut 2001, 48:526-535.
4. Sartor R.B. Microbial influences in inflammatory bowel diseas. Gastroenterology 2008, 134:577-594.
5. Wirtz S., Neufert C., Weigmann B., Neurath M.F. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007, 2:541-546.
6. Dieleman L.A., Palmen M.J., Akol H., Bloemena E., Pena A.S., et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998, 114:385-391.
7. Yan Y., Kolachala V., Dalmasso G., Nguyen H., et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 2009, 4:e6073.
8. Laroui H., Ingersoll S.A., Liu H.C., Baker M.T., et al. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS ONE 2012, 7(3):e32084.
9. Subramaniam D., Giridharan P., Murmu N., Shankaranarayanan N.P., May R., et al. Activation of apoptosis by 1-hydroxy-5, 7-dimethoxy-2-naphthalene-carboxaldehyde, a novel compound from Aegle marmelos. Cancer Res 2008, 68:8573-8581.
10. Shankarananth V., Balakrishnan N., Suresh D., Sureshpandian G., Edwin E., Sheeja E. Analgesic activity of methanol extract of Aegle marmelos leaves. Fitoterapia 2007, 78:258-259.
11. Kesari A.N., Gupta R.K., Singh S.K., Diwakar S., Watal G. Hypoglycemic and antihyperglycemic activity of Aegle marmelos seed extract in normal and diabetic rats. J Ethnopharmacol 2006, 107:374-379.
12. Chopra R.N., Nayar S.L., Chopra I.C. Glossary of Indian Medicinal Plants 1956, 8. CSIR, New Delhi, India.
13. Jagtap A.G., Shirke S.S., Phadke A.S. Effect of a polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol 2004, 90:195-204.
14. Shoba F.G., Thomas M. Study of antidiarrhoeal activity of four medicinal plants in castor-oil induced diarrhoea. J Ethnopharmacol 2001, 76:73-76.
15. Maity P., Hansda D., Bandyopadhyay U., Mishra D.K. Biological activities of crude extracts and chemical constituents of Bael, Aegle marmelos (L.). Corr Indian J Exp Biol 2009, 47:849-861.
16. Raja S.B., Murali M.R., Devaraj S.N. Differential expression of ompC and ompF in multidrug resistant Shigella dysenteriae and Shigella flexneri by aqueous extract of Aegle marmelos, altering its susceptibility toward beta-lactam antibiotics. Diagn Microbiol Infect Dis 2008, 61:321-328.
17. Raja S.B., Murali M.R., Roopa K., Devaraj S.N. Imperatorin a furocoumarin inhibits periplasmic Cu-Zn SOD of Shigella dysenteriae their by modulates its resistance towards phagocytosis during host pathogen interaction. Biomed Pharmacother 2011, 65(8):560-568.
18. Raja S.B., Murali M.R., Kumar N.K., Devaraj S.N. Isolation and partial characterisation of a novel lectin from Aegle marmelos fruit and its effect on adherence and invasion of Shigellae to HT29 cells. PLoS One 2011, 6(1):e16231.
19. Adedapo A.A., Jimoh F.O., Afolayan A.J., Masika P.J. Antioxidant activities and phenolic contents of the methanol extracts of the stems of Acokanthera oppositifolia and Adenia gummifera. BMC Complement Altern Med 2008, 8:54.
20. Vinholes J., Grosso C., Andrade P.B., Gil-Izquierdo A., et al. In-vitro studies to assess the antidiabetic, anti-cholinesterase and antioxidant potential of Spergularia rubra. Food Chem 2011, 129:454-462.
21. Cooper H.S., Murthy S.N., Shah R.S., Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993, 69:238-249.
22. Elango C., Devaraj S.N. Immunomodulatory effect of Hawthorn extract inan experimental stroke model. J Neuroinflammation 2010, 7:97. 10.1186/1742-2094-7-97.
23. Trott O., Olson A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 2010, 31:455-461.
24. Temple N.J. Antioxidants and disease: more questions than answers. Nutr Res 2000, 20:449-459.
25. Blumberg R.S., Saubermann L.J., Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999, 11:648-656.
26. Kumar K.N., Raja S.B., Vidhya N., Devaraj S.N. Ellagic acid modulates antioxidant status, ornithine decarboxylase expression, and aberrant crypt foci progression in 1,2 dimethylhydrazine-instigated colon preneoplastic lesions in rats. J Agric Food Chem 2012, 60:3665-3672.
27. Brand-Williams W., Cuvelier M.E., Berset C. Use of free radical method to evaluate antioxidant activity. Food Sci Technol-Leb 1995, 28:25-30.
28. Benzie I.F.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996, 239:70-76.
29. Cao G., Alessio H.M., Cutler R.G. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 1993, 14:303-311.
30. Huang D., Ou B., Prior R.L. The chemistry behind antioxidant capacity assays. J Agric Food Chem 2005, 53:1841-1856.
31. Sanchez-Moreno C., Larraui A., Saura-Calixto F. A procedure to measure the antiradical efficiency of polyphenols. J Sci Food Agri 1998, 76:270.
32. Karagözler A.A., Erdag B., Emek Y.C., Uygum D.A. Antioxidant activity and proline content of leaf extracts from Dorystoechashastata. Food Chem 2008, 111:400-407.
33. Das B., Das R. Medicinal properties and chemical constituents of Aegle marmelos Correa. Indian Drugs 1995, 32:93-99.
34. Roy S.K., Singh R.N. Bael fruit (Aegle marmelos) - a potential fruit for processing. Econ Bot 1979, 33:203-212.
35. Gonzalez-Rey E., Chorny A., Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroentrology 2006, 130:1701-1720.
36. Eu-Jin C., Ji-Sun S., Kyung-Sook C., Yong Sup L., et al. Arvelexin inhibits colonic inflammation by suppression of NF-κB activation in dextran sulfate sodium-induced mice and TNF-α-induced colonic epithelial cells. J Agric Food Chem 2012, 60:7398-7407.
37. Atreya I., Atreya R., Neurath M.F. NF-kappaB in inflammatory bowel disease. J Intern Med 2008, 263:591-596.
38. Yamamoto Y., Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001, 107:135-142.
39. Piccagli L., Fabbri E., Borgatti M., Bezzerri V., Mancini I., Nicolis E., et al. Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF kappaB/DNA interactions and inhibitory effects on IL-8 gene expression. BMC Struc Biol 2008, 8:8-38. 10.1186/14726807838.
40. Velayos F. Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices. Expert Rev Gastroenterol Hepatol 2008, 2(6):817-825.
41. Clapper M.L., Cooper H.S., Chang W.L. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 2007, 28:1450-1459.
42. Tanaka T., Kohno H., Suzuki R., Hata K., Sugie S., et al. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc Min/1 mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer 2006, 118:25-34.
43. Gandhi G.R., Ignacimuthu S., Paulraj M.G. Hypoglycemic and b-cells regenerative effects of Aegle marmelos (L.) Corr Bark extract in streptozotocin-induced diabetic rats. Food Chem Toxicol 2012, 50:1667-1674.
44. Govinda H.V., Asdaq S.M.B. Immunomodulatory potential of methanol extract of Aegle marmelos in animals. Indian J Pharm Sci 2011, 73:35-240.
45. Solomon L., Mallon P., Donnelly E., Hoper M., et al. The dextran sulphate sodium (DSS) model of colitis: an overview. Comp Clin Pathol 2010, 19:235-239.
46. Friedman D.J., Künzli B.M., A-Rahim Y.I., Sevigny J., et al. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 2009, 106:16788-16793.
47. Reynolds W.F., Patel K., Pianko S., et al. Genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection. Genes Immun 2002, 3:345-349.
48. Schreiber S., et al. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's Disease. Gastronterology 2000, 119:1461-1472.
49. Marrero J.A., Matkowskyj K.A., Yung K., Hecht G., Benya R.V. Dextran sulfate sodium-induced murine colitis activates NF-kappaB and increases galanin-1 receptor expression. Am J Physiol Gastrointest Liver Physiol 2000, 278:G797-G804.